Key result
ATGL knockdown in human aortic endothelial cells enhanced monocyte adhesion through increased TNFα-induced ICAM-1 expression via activation of NFκB and PKC.
Reduced ATGL expression enhances monocyte adhesion via TNFα-induced ICAM-1 expression, suggesting a mechanism for accelerated atherosclerosis in insulin-resistant states.
Hypothesis-generating for ATGL in endothelial inflammation; leaves open its role in human atherosclerosis progression.
We examined the effects of adipose triglyceride lipase (ATGL) on the initiation of atherosclerosis. ATGL was recently identified as a rate-limiting triglyceride (TG) lipase. Mutations in the human ATGL gene are associated with neutral lipid storage disease with myopathy, a rare genetic disease characterized by excessive accumulation of TG in multiple tissues. The cardiac phenotype, known as triglyceride deposit cardiomyovasculopathy, shows massive TG accumulation in both coronary atherosclerotic lesions and the myocardium. Recent reports show that myocardial triglyceride content is significantly higher in patients with prediabetes or diabetes and that ATGL expression is decreased in the obese insulin-resistant state. Therefore, we investigated the effect of decreased ATGL activity on the development of atherosclerosis using human aortic endothelial cells. We found that ATGL knockdown enhanced monocyte adhesion via increased expression of TNFα-induced intercellular adhesion molecule-1 (ICAM-1). Next, we determined the pathways (MAPK, PKC, or NFκB) involved in ICAM-1 up-regulation induced by ATGL knockdown. Both phosphorylation of PKC and degradation of IκBα were increased in ATGL knockdown human aortic endothelial cells. In addition, intracellular diacylglycerol levels and free fatty acid uptake via CD36 were significantly increased in these cells. Inhibition of the PKC pathway using calphostin C and GF109203X suppressed TNFα-induced ICAM-1 expression. In conclusion, we showed that ATGL knockdown increased monocyte adhesion to the endothelium through enhanced TNFα-induced ICAM-1 expression via activation of NFκB and PKC. These results suggest that reduced ATGL expression may influence the atherogenic process in neutral lipid storage diseases and in the insulin-resistant state.Background: Adipose triglyceride lipase (ATGL) expression is decreased in the obese insulin-resistant state.Results: RNA interference-mediated down-regulation of ATGL enhanced monocyte adhesion via increased expression of tumor necrosis factor α-induced intercellular adhesion molecule-1.Conclusion: Reduced ATGL expression may influence the atherogenic process in the insulin-resistant state.Significance: This mechanism also leads to the acceleration of atherosclerosis in patients with insulin-resistance, even if not in a state of hyperglycemia. We examined the effects of adipose triglyceride lipase (ATGL) on the initiation of atherosclerosis. ATGL was recently identified as a rate-limiting triglyceride (TG) lipase. Mutations in the human ATGL gene are associated with neutral lipid storage disease with myopathy, a rare genetic disease characterized by excessive accumulation of TG in multiple tissues. The cardiac phenotype, known as triglyceride deposit cardiomyovasculopathy, shows massive TG accumulation in both coronary atherosclerotic lesions and the myocardium. Recent reports show that myocardial triglyceride content is significantly higher in patients with prediabetes or diabetes and that ATGL expression is decreased in the obese insulin-resistant state. Therefore, we investigated the effect of decreased ATGL activity on the development of atherosclerosis using human aortic endothelial cells. We found that ATGL knockdown enhanced monocyte adhesion via increased expression of TNFα-induced intercellular adhesion molecule-1 (ICAM-1). Next, we determined the pathways (MAPK, PKC, or NFκB) involved in ICAM-1 up-regulation induced by ATGL knockdown. Both phosphorylation of PKC and degradation of IκBα were increased in ATGL knockdown human aortic endothelial cells. In addition, intracellular diacylglycerol levels and free fatty acid uptake via CD36 were significantly increased in these cells. Inhibition of the PKC pathway using calphostin C and GF109203X suppressed TNFα-induced ICAM-1 expression. In conclusion, we showed that ATGL knockdown increased monocyte adhesion to the endothelium through enhanced TNFα-induced ICAM-1 expression via activation of NFκB and PKC. These results suggest that reduced ATGL expression may influence the atherogenic process in neutral lipid storage diseases and in the insulin-resistant state. Background: Adipose triglyceride lipase (ATGL) expression is decreased in the obese insulin-resistant state. Results: RNA interference-mediated down-regulation of ATGL enhanced monocyte adhesion via increased expression of tumor necrosis factor α-induced intercellular adhesion molecule-1. Conclusion: Reduced ATGL expression may influence the atherogenic process in the insulin-resistant state. Significance: This mechanism also leads to the acceleration of atherosclerosis in patients with insulin-resistance, even if not in a state of hyperglycemia.
No takes yet. Share an insight, caveat, or question.
Inoue et al. (2011) studied Atherosclerosis. ATGL knockdown vs. Control cells was evaluated on Monocyte adhesion and TNFα-induced ICAM-1 expression. ATGL knockdown in human aortic endothelial cells enhanced monocyte adhesion through increased TNFα-induced ICAM-1 expression via activation of NFκB and PKC.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: